A molecular brake on dendritic cell activation
Nature Medicine
December 15, 2011
A natural molecular brake in immune cells prevents autoimmune diabetes in mice, according to a report in Nature Medicine. These findings highlight one way in which the immune system prevents excessive activation and autoimmunity.
Dendritic cells are a type of immune cell that once activated, are critical for triggering an adaptive immune response. Most studies to date have focused on identifying factors that promote the maturation, activation and survival of dendritic cells.
Pamela Ohashi and her colleagues report that Nuclear Factor-kB1 (NF-kB1), a transcription factor that regulates inflammatory responses, is normally expressed in immature dendritic cells and holds them in a resting state. Dendritic cells lacking NF-kB1 become activated, release pro-inflammatory cytokines and stimulate T cell immune responses. In turn, these activated T cells attack pancreatic islets and cause autoimmune diabetes in mice.
doi: 10.1038/nm.2556
Research highlights
-
Jun 24
Palaeontology: It sucked to be the prey of ancient cephalopodsScientific Reports
-
Jun 24
Sport science: New wearable sensor to measure neck strain may detect potential concussionScientific Reports
-
Jun 23
Scientific community: Women credited less than men in scientific paper authorshipNature
-
Jun 17
Health technology: New cost-effective smartphone test for middle ear functionCommunications Medicine
-
Jun 17
Conservation: Feral cats pushing critically endangered marsupial further towards extinctionScientific Reports
-
Jun 16
Microbiology: DNA analysis indicates origins of the Black DeathNature